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Kaposi's sarcoma (KS) is a complex neoplasm comprising 
spindle cells, vascular structures, erythrocytes, and an inflam-
matory infiltrate. The pathogenesis of this disorder is not yet 
understood, which is a major impediment to the design of 
safe and effective new therapies. We previously reported a 
murine model in which simian virus 40 (SV40) T-antigen-
transformed murine endothelial cells induce lesions with the 
histopathologic features of KS. We have now cloned by lim-
T he behavior of a tumor reflects the biology of both the host and the cell of origin. Kaposi's sarcoma (KS) remains a biologic enigma because neither of these determinants are well characterized. This unusual non-metastatic, multifocal neoplasm consists of sev-
eral cellular components: vascular structures, spindle cells, dendritic 
cells, and an inflammatory infiltrate [1]. Attempts to clarify the 
cellular origin ofKS using markers defining normal cells have led to 
a confusing array of candidates, including cells of endothelial [2,3], 
smooth muscle [4,5]' and dendritic [6] derivation, a reminder that 
cells derived from tumors are not normal and may pose special 
problems in their characterization [7] . In an effort to understand the 
cell biology of complex tumors such as KS, we have induced tumors 
using a well-characterized endothelial cell in a murine model. We 
previously reported that injection of a well-differentiated simian 
virus 40 (SV 40) - transformed murine microvascular endothelial 
cell line into nude mice induces non-metastatic tumors that share 
the histopathologic features ofKS, including vascular structures and 
spindle cells [8]. Because SV40 is non-permissive in mouse cells, 
only the T -antigen gene is transcribed. The T antigen, which is the 
transforming protein of SV 40, is stably expressed in the nucleus of 
the murine cell and its progeny [9]. We utilized this viral marker to 
definitively identify the cellular origin of epithelioid and spindle 
cell lines cloned from these tumors. 
MATERIALS AND METHODS 
Cell Lines Derivation and characterization of SVEC4-10 has 
been described elsewhere [10]. This cell was derived from C3H/ 
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iting dilution seven morphologically distinct tumor-derived 
lines, all of which express the SV 40 T antigen. Because SV 40 
is non-permissive in mouse cells, the presence of this viral 
marker permits definitive identification of cellular origin. 
We report here that both spindle cell and epithelioid cell 
clones from these KS-like tumors are derived from endothe-
lial cells. ] Invest DermatoltoO:742 - 745, 1993 
He] (H-2k) peripheral lymph node transformed by high-multiplic-
ity infection with SV40. SVEC4-10 grows without exogenous en-
dothelial growth factors and extracellular matrix components yet 
retains the functional characteristics of normal microvascular endo-
thelial cells. Tumor explant lines were derived as described/revi-
ously [8] . All cell lines were cloned by limiting dilution an were 
maintained without antibiotics in Dulbecco's modified Eagle's me-
dium containing 10% fetal bovine serum (Gibco, Grand Island, 
NY). Spindle cells in the crude explant cultures were a minor con-
stituent and had a slower doubling time. Initial cloning by limiting 
dilution resulted in no spindle-cell isolates. SVEC4-10EHR1 was 
eventually cloned by two rounds of limiting dilution using medium 
conditioned by SVEC4-1 OEE2 [8]; it now grows in Dulbecco's mod-
ified Eagle's medium 10%. All lines are negative for mycoplasma by 
DNA hybridization; co-culture with CV-1 African green monkey 
kidney cells (American Type Culture Collection) has revealed no 
evidence of productive viral infection. 
Antibodies The following antibodies were used: mouse mono-
clonal anti-SV40 T antigen at 1: 100 (Oncogene Sciences, Manhas-
set, NY) and mouse monoclonal 11.4-1 (anti - H_2k) at 1 : 200 (Bec-
ton Dickinson, Mountain View, CA). Secondary antibody for 
immunofluorescence was goat anti-mouse immunoglobulin G con-
jugated to fluorescein isothiocyanate (Dako, Carpentia, CA); bio-
tinylated goat anti-mouse immunoglobulin G (Dako) was used for 
immunophosphatase staining of tissue sections. 
Immunohistochemistry Cells for assay were grown on glass 
coverslips in medium containing gentamicin and were rinsed in 
phosphosphate-buffered saline and fixed for 3 min in cold metha-
nol. Tissue was snap-frozen in OTC using liquid nitrogen and 
stored at -70°C. Five-micrometer sections were cut using a cryo-
stat and were fixed for 10 min in cold acetone, followed by air 
drying and rehydration in 0.05 M Tris(hydroxymethyl)amino-
methane buffer containing 1 mM levamisole (Dako) to block en-
dogenous phosphatases . Normal mouse serum was used as a nega-
tive control; all reagents were used as recommended by the supplier. 
Slides were counterstained with Mayer's hematoxylin. Tissue for 
histopathologic examination was fixed in 10% buffered formalin 
and embedded in paraffin for routine processing and staining with 
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Figure 1: Monolayer l.n0rphology of cloned, ~ransformed e.ndothelial cell lines; bar, 100 /.I.m. Insets, immunofluorescent staining ofT antigen in the nuclei 
using antl-SV40 T antigen antIbody, as descnbed 111 Materrals and Met/lods; bar, 30/1m. (A) SVEC4-10, original transformant; (B) SVEC4-l0EE2; (C) 
SVEC4-10EHR1; (D) 2F-2B; (E) 2H-ll; (F) 3B-ll; (G) IP-1B; (H) IP2-E4. 
hematoxylin and eosin . Cultured cells were photographed using a 
Nikon TMS inverted-phase scope and Kodak Tmax 100 black-and-
white film.. 
Tumorigenesis Virus-free CDI (outbred) nu/nu male mice 
from Charles River (Wilmington, MA) were housed in a germ-free 
facility in laminar flow cages according to institutional guidelines; 
5 X 106 viable transformed cells were injected in 0.2-ml sterile sa-
line using the intraperitoneal or subcutaneous route, as noted. Mice 
were observed carefully for signs of discomfort and were euthanized 
by cervical dislocation. Harvested tumors were trisected using asep-
tic technique and processed as noted above. 
RESULTS 
As previously reported [8], initial cloning from the murine KS-l ike 
tumors resulted in an epithelioid cell line (SVEC4-10EE2), which 
expresses the viral T antigen as well as endothel ial markers, Fac-
tor VIII - related antigen (von Willebrand) and acetylated low-
density - lipoprotein receptor. This cell line also induces KS-like 
tumors in n ude mice. W e were subsequently able to clone a distinct 
spindle cell line with a markedly s lo~er growth rate using medium 
conditioned by SVEC4-10EE2. TIllS cell Ime, SVEC4-10EHRl, 
also expresses the viral T antigen (Fig 1 C). Thus, the spindle cell, 
like the epithelioid cell (Fig IB), is derived from the original endo-
thelial cell line, SVEC4-1 0 (Fig l A ). This spindle-cell line also 
expresses the cell-surface major histocompatibility complex class I 
antigen of the original cell line, H_2k (not shown). Established and 
stabilized i 11 vitro, this cell line does not dIffer from the others in 
growth r a te or requirements; its monolayer morphology consists of 
overlapping spindle cells with intercellular gaps. 
When injected into nu/nu mice, this spindle cell induced nodular 
tumors with the histopathologic characteristics of human nodular 
KS. As seen in Fig 2, these features include fascicles of interlacing 
spindle cells with anaplastic features, small vascu lar slits containing 
red blood cells, and a mononuclear cell infiltrate. Intraperitoneal 
injection resulted in nodular tumors throughout the intraperitoneal 
connective tissues. Several of these mice also developed a hemor-
rhagic ascites with large numbers of T -antigen - negative macro-
phage-like cells interspersed with occasional T-antigen-positive 
tumor cells. Microscopic tumors were occasionally seen in paren-
chymal tissues, including the lung, a site not involved in mice 111-
j ected with SVEC4-10 or SVEC4-lOEE2 [8]. The time from inJec-
tion to clinically significant disease was consistent with our prevIous 
findings, approximately 14 weeks. Immunophosphatase staining of 
frozen tumor sections, shown in Fig 3, confirmed the presen~e ofT 
antigen in the nuclei of the tumor cells, establishing their denvatlon 
from the original endothelial cell line. . . 
T he isolation of morphologica lly distinct clones of defirutlve 
endothelial cel l origin provides a system for elucidatin~ the genetIc 
and epigenetic determinants of endothelial cell tumongenesls and 
differentiation. T hird-generation cell lines have thus been cloned 
from the epithelioid and spindle cell - induced tumors .. 2F-2B, 
shown in Fig ID, was derived from an SVEC4-10EE2-mduced 
nodular cutaneous tumor. 2H-ll was derived from a nodular 
SVEC4-10EHRl-induced spindle cell tumor. The remaining 
three clones, IP-IB, 3B-ll , and IP2-E4, were derived from 
SVEC4-1 OEHR 1 - induced ascites tumors. As shown in Fig 1, 
these clones are morphologica lly distinct, none of them display-
ing the distinctive biphasic morphology of SVEC4-10; yet all are 
T -antigen positive. Furthermore, they all express the major histo-
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compatibility complex class I haplotype of the original line (not 
shown) . 
DISCUSSION 
KS is an unusual disease characterized by a multifocal proliferation 
of spindle cells and vascular structures. Since its original description 
in 1872 [11]. it has remained an enigma despite its dramatic re-
emergence in epidemic form associated with acquired immunodefi-
ciency syndrome. The epidemiology and cell biology of KS are 
confusing and have left unresolved even the most basic questions, 
such as cellular origin, the role of viral genes in pathogenesis, and 
the contribution of immune suppression. Confusion surrounding 
the cellular origin of KS reflects the complex histopathology of the 
lesions, which consist of spindle cells, abnormal vascular spaces, 
dendritic cells, and a lymphoplasmacytoid inflammatory infiltrate 
[1] . Although there is evidence that both the vascular cell and the 
spindle cell are of endothelial origin [2,3]' other studies have sug-
gested that the spindle cell arises from smooth muscle [4,5] or bone 
marrow-derived dendritic cells [6]. Attempts at clarification are 
complicated because cells derived from tumors may not express the 
phenotypic and functional markers of their normal counterparts 
l7, 12]. Animal models proposed for studying this disease have been 
based on the introduction of an infectious agent or human-derived 
KS cells into mice, but the resulting lesions present the same para-
dox in characterization [12-14]. 
The model system used here is unique because the lesions are 
induced by a definitively identified cell line whose progeny can be 
traced via a viral marker that is independent of tumor-associated 
derangements in differentiative phenotype. Using this system we 
have established that tumors histopathologically very similar to 
human KS can be induced in nude mice by virally altered endothe-
lial cells and that both spindle cells and cuboidal cells derived from 
these tumors are of endothelial origin. The stability of these pheno-
types in vitro provides a unique opportunity to delineate the genetic 
and epigenetic determinants of endothelial differentiation and their 
contribution to tumorigenesis. 
The epidemiology of human KS is highly suggestive of a viral 
etiology in the context of pre-existing immunosuppression [15]. 
Identification of the putative agent has remained elusive, although 
roles have been proposed for the human immunodeficiency virus 
[16], other unknown retroviruses [17], and several DNA viruses, 
including cytomegalovirus [18], human papillomavirus [19,20], and 
BK virus [21]. It appears now that human immunodeficiency virus 
contributes to KS pathogenesis as mediator of the immunosuppres-
sion requisite for the appearance of clinical disease but is not the 
direct etiologic agent. The DNA virus candidates also present in-
conclusive evidence for a direct role, but it is interesting to note that 
human papillomavirus and BKV are members of the papovavirus 
family to which SV40 belongs. Although it is clear from this model 
that the SV40 T antigen has induced physiologic changes in the 
endothelial cells contributing to tumorigenesis, the lengthy lag pe-
riod suggests an important role for host-defined factors in selection 
of the tumorigenic phenotype. 
The normal endothelial cell functions as a polarized cell attached 
to a basement membrane, characteristic of epithelial cells. Tumori-
genic endothelial cells growing within connective tissue extracellu-
lar matrix inhabit an environment more typical of mesenchymal 
cells. Studies are underway to define the interactions of the cloned 
cells with extracellular matrix and to determine whether the mesen-
chymal morphology of the spindle cell c1ones 'is accompanied by 
functional markers of mesenchymal differentiation. The idea that 
normal endothelial cells "transdifferentiate" has recently been in-
vestigated by Karasek and co-workers [22], who have proposed that 
the phenotype of the normal endothelial cell is regulated by cyclic 
adenosine monophosphate (cAMP) - dependent mechanisms. Ac-
cordingly, in the presence of cAMP, the normal endothelial cell 
assumes a distinctive monolayer morphology characterized by nests 
of cuboidal cells surrounded by bands of broad, flattened bipolar 
cells . On removal of cAMP, the cell enters a transitional stage of 
broad, flattened bipolar cells, followed by irreversible acquisition of 
the true spindle cell morphology of fully trans differentiated cells; 
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this morphologic switch is accompanied by functional changes 
characteristic of mesenchymal cells. The functional consequences 
of such endothelial cell transdifferentiation ill vivo are unexplored. 
As shown in Fig lA, the original isolate, SVEC4-10, displays the 
distinctive monolayer morphology of actively dividing normal en-
dothelial cells, as described previously by Karasek and co-workers 
[22]. Unlike these normal endothelial cells, however, SVEC4-10 
maintains this morphology in the absence of dibutyryl cAMP. This 
biphasic morphology is not simply a characteristic of actively divid-
ing endothelial cell cultures because the tumor-derived, morpholog-
ically distinct clones grow equally well. We previously reported 
that tumor necrosis factor induces SVEC4-10 to undergo reversible 
transition to a spindle cell morphology [10], a characteristic of nor-
Figure 2. Histopathology of SVEC4-10EHR1 - induced tumor in nude 
mouse: (A) skin nodule demonstrating fascicles of spindle cells (bar, 25 J1) ; 
(B) connective tissue - associated nodule showing inflammatory infiltrate 
(wide arrow) and slitlike spaces containing erythrocytes ("arrow arrow) (bar, 
75 J1). 
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Figure 3_ . (A) Immunophosphat~se staini?g of frozen-section SVEC4-
10EHR 1 -Induced tumor USll1g pnmary antibody agall1st SV40 T antigen; 
(B) control sectio~ using normal serum. Sections countersta ined with 
Mayer's hematoxyltn; bar, 12.5 11m. 
JTlal endothelial cells activated by this immune cytokine. This sug-
gests that SV40 transformatIOn alone h as not altered the ability of 
the cells to accomplish the cytoskeletal rearrangements necessary 
for endothelial cell transdifferentiation [22]. Studies a re underway 
t~ deterITline whether selection for tumorigenicity is linked to loss 
of this functional characteristic. 
Transdifferentiation. as discussed by Okada [23] in the context of 
developITlent, is a switch in the phenotype of a mature cell by micro-
environITlent-determined activation of cell type-specific gene tran-
scription. Hay [24] proposed master genes that function during 
developITlent under the 1l1fluence of the extracellular matrix to in-
hibit transdifferentiation, thus maintaining the structural "order" 
oftissues. The tumor-derived endothelial cell clones described here 
JTl3Y represent altera tions in such genes or their expression by host 
factors. The predilection in our system for tumor growth within 
connective tissue suggests involvement of the extracellular matrix. 
If such changes are linked to selection of tumorigenic cells, our data 
indicate that they do not affect tumor latency. Other host factors, 
$Uch as the immune response, may operate to determine this parame-
ter of tuITlorigenesis (manuscript in preparation). 
Understanding the biology of endoth elial cell -derived tumors 
promises to define control of endothelial cell differentiation and 
refine our concept of malignancy, a concept that has evolved largely 
from an eInphasis on genetic changes in cancer cells . KS and tumors 
like it ITlay serve to remind us that the "soil" is as important as the 
"seed. " 
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